Researchers find rare genetic cause of Tourette syndrome

by Bill Hathaway
Researchers find rare genetic cause of Tourette syndrome
Credit: Shutterstock

A rare genetic mutation that disrupts production of histamine in the brain is a cause of the tics and other abnormalities of Tourette syndrome, according to new findings by Yale School of Medicine researchers.

The findings, reported Jan. 8 in the journal Neuron, suggest that existing drugs that target histamine receptors in the brain might be useful in treating the disorder. Tourette syndrome afflicts up to 1% of children, and a smaller percentage of adults.

"These findings give us a new window into what's going on in the brain in people with Tourette. That's likely to lead us to new treatments," said Christopher Pittenger, associate professor in the psychiatry and psychology departments and in the Yale Child Study Center, and senior author of the paper.

Histamine is commonly associated with allergy, but it also plays an important role as a signaling molecule in the brain. Interactions with this brain system explain why some allergy medications cause people to feel sleepy.

In 2010, Yale researchers showed that a family with nine members suffering from Tourette's carried a mutation in a gene called HDC that disrupts the production of histamine. The new work demonstrates that this mutation causes the disorder. Mice with the same mutation develop symptoms similar to those found in Tourette's, the Yale team showed. Also, these mice and the patients that carry the HDC mutation showed in signaling by the neurotransmitter dopamine in parts of the brain associated with Tourette's and related conditions.

Drug companies have developed medications that target -specific histamine receptors in an effort to treat schizophrenia and ADHD. While not approved for general use yet, those drugs or others that target histamine receptors should be tested to see whether they can treat symptoms of Tourette syndrome, Pittenger said.

Related Stories

Deep brain stimulation powerful in treating Tourette's

date Aug 16, 2012

Ten out of 11 patients with severe Tourette’s Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of ...

New treatment for schizophrenia discovered

date Jul 01, 2013

A research group led by professor Jesper Ekelund showed that by giving a very large dose of famotidine (200 mg daily), sufficient amounts of the drug are able to penetrate the so-called blood-brain barrier ...

Recommended for you

Living life in the third person

date 14 hours ago

Imagine living a healthy, normal life without the ability to re-experience in your mind personal events from your past. You have learned details about past episodes from your life and can recite these to ...

Guideline advises when to treat a first seizure

date 15 hours ago

A new guideline released today by the American Academy of Neurology (AAN) and the American Epilepsy Society (AES) found that administering an antiepileptic medication immediately after a first seizure reduces the risk of ...

Brain: A 'cingular' strategy for attack and defense

date 20 hours ago

Researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to choosing strategies, specifically deciding to attack an opponent or defend one's position.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.